More Globe Newswire

View Older Stories View Newer Stories

Jan 5, 2024 07:30AM Constellation Brands Reports Third Quarter Fiscal 2024 Financial Results
Jan 5, 2024 07:30AM TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Jan 5, 2024 07:30AM Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Jan 5, 2024 07:30AM Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
Jan 5, 2024 07:30AM Bitech Technologies Receives Initial Purchase Order for its Innovative Energy-Saving VPP Solution to Enter the Building Energy Management System (BEMS) Market
Jan 5, 2024 07:17AM RCLCO Ranks Summerlin® and Bridgeland® Among Nation’s Top Five Best-Selling Master Planned Communities of 2023
Jan 5, 2024 07:08AM Alliance Trust PLC - Net Asset Value
Jan 5, 2024 07:00AM Pan American Energy Corp Announces Filing of Inaugural NI 43-101 Technical Report For The Horizon Lithium Project
Jan 5, 2024 07:00AM Clean Earth Names New Chief Commercial Officer
Jan 5, 2024 07:00AM Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation
Jan 5, 2024 07:00AM Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
Jan 5, 2024 07:00AM ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration
Jan 5, 2024 06:55AM Wabash Schedules Fourth Quarter 2023 Earnings Conference Call
Jan 5, 2024 06:50AM Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities
Jan 5, 2024 06:45AM Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Jan 5, 2024 06:45AM Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer
Jan 5, 2024 06:30AM Turning Point Brands Canada Named Exclusive Master Distributor for VPR Brands' HoneyStick in Canada
Jan 5, 2024 06:30AM Hut 8 Operations Update for December 2023
Jan 5, 2024 06:30AM Turning Point Brands Canada Named Exclusive Master Distributor for VPR Brands' HoneyStick in Canada
Jan 5, 2024 06:20AM Iris Energy Announces Monthly Investor Update for December 2023
Jan 5, 2024 06:20AM Multitude SE Contemplates a Relocation to Switzerland
Jan 5, 2024 06:14AM Net Asset Value(s)
Jan 5, 2024 06:05AM CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
Jan 5, 2024 06:00AM Precision Drilling Meets 2023 Debt Repayment and Share Repurchase Targets and Provides Capital Allocation, Financial and Operational Updates
Jan 5, 2024 06:00AM Precision Drilling Meets 2023 Debt Repayment and Share Repurchase Targets and Provides Capital Allocation, Financial and Operational Updates
Jan 5, 2024 06:00AM Bionomics to Present at Biotech Showcase™ 2024
Jan 5, 2024 06:00AM Kymera Therapeutics Announces Pricing of $275 Million Public Offering
Jan 5, 2024 06:00AM Trio Petroleum Corp Announces an Option to Acquire a 20% Interest in the Asphalt Ridge Development Project in Utah
Jan 5, 2024 06:00AM AR Exhibition “Ragnarok Real World Experience” to Open in Thailand
Jan 5, 2024 06:00AM Verano Broadens Retail Footprint in Northeast Florida with the Opening of MÜV Yulee, the Company’s 74th Florida Location
Jan 5, 2024 05:55AM ASHTON WOODS USA L.L.C. ANNOUNCES QUARTERLY RESULTS CONFERENCE CALL
Jan 5, 2024 05:24AM 17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
Jan 5, 2024 04:29AM Form 8.5 (EPT/RI) - Velocys Plc
Jan 5, 2024 04:16AM Dimensional Fund Advisors Ltd. : Form 8.3 - LXI REIT PLC
Jan 5, 2024 04:14AM Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC
Jan 5, 2024 04:09AM Form 8.5 (EPT/RI) - musicMagpie Plc
Jan 5, 2024 04:00AM RealManage Promotes Amber Orduño to SVP, Client Success
Jan 5, 2024 04:00AM selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024
Jan 5, 2024 03:05AM Claims process now closed for the Day Scholars Class Action Settlement
Jan 5, 2024 03:00AM Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares in connection with share buy-back program
Jan 5, 2024 03:00AM Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer
Jan 5, 2024 03:00AM STMicroelectronics Announces Timing for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Jan 5, 2024 03:00AM Offentliggørelse af prospekt for Investeringsforeningen Nordea Invest
Jan 5, 2024 03:00AM Dassault Systèmes: Half-year statement of the Liquidity contract entered into with Oddo BHF SCA
Jan 5, 2024 02:41AM Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
Jan 5, 2024 02:37AM Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
Jan 5, 2024 02:35AM Form 8.5 (EPT/RI) - Smart Metering Systems plc
Jan 5, 2024 02:30AM VALNEVA - Declaration of shares and voting rights: December 31, 2023
Jan 5, 2024 02:20AM Lerøy Seafood Group ASA: Trading update Q4 2023
Jan 5, 2024 02:15AM Bekaert - Update on the Share Buyback Program
View Newer Stories View Older Stories